Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer

Lung Cancer

Volumn 33, Issue 2-3, 2001, Pages 99-107

  Marom, Edith M ^a   Aloia, Thomas A ^a   Moore, Mary Beth ^a   Hara, Masaki ^b   Herndon II, James E ^a   Harpole Jr , David H ^a   Goodman, Philip C ^a   Patz Jr , Edward F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Glucose transporter; Lung cancer; PET

Indexed keywords

GLUCOSE TRANSPORTER;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 3; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034894785     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00250-6     Document Type: Article

References (29)

1. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture
2. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer
3. Energy metabolism of tumor cells: Requirement for a form of hexokinase with a propenssity for mitochondrial binding
4. 18F]-FDG in oncology: a clinical update
5. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings
6. Atypical manifestations of pulmonary adenoid cystic carcinoma
7. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions
8. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging non-small cell lung cancer
9. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models
10. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
11. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study
12. Characterization of chest masses by FDG positron emission tomography
13. Evaluation of pulmonary lesions with FDG-PET
14. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography
15. Prospective investigation of PET in lung nodules (PIOPILN)
16. Staging non-small cell lung cancer with whole body positron emission tomography
17. Facilitative glucose transporters
18. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects
19. Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study
20. Immunohistochemimcal localization of glucose transporters in human renal cell carcinoma
21. The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models
22. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning
23. Positron emission tomography imaging in lung cancer
24. Thoracic nodal staging with positron emission tomography (PET) and 18-F-2 fluoro-2-deoxy-D-glucose in patients with bronchogenic carcinoma
25. Diagnosis of bone metastasis in lung cancer by whole-body PET-PDG imaging: Comparison to conventional skeletal scintigraphy
26. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation
27. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue
28. Glut1 expression in human breast carcinoma: correlation with known prognostidc markers
29. Overexpression of Glut 1 and Glut3 in stage 1 nonsmall cell lung carcinoma is associated with poor survival